Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Novel in Vivo Synaptic Imaging in Experienced Meditators
NCT05418608Phase 1Completed
- Sponsor
- Yale University
- Start
- Apr 2022
- Primary completion
- Apr 2024
- Countries
- 1
01
Overview
Phase 1, open-label trial of 11C-UCB-J (2 arms), sponsored by Yale University. Primary endpoint: Binding Potential Using Synaptic Density at 6 months. Started Apr 2022; status: completed.
02
Drugs
11C-UCB-J
Beyond the preview
Go deeper on NCT05418608.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05418608.